Cellavision AB 

$14.00
10
+$0.51+3.78% Tuesday 20:00

Statistics

Day High
15
Day Low
13.49
52W High
19.28
52W Low
13.49
Volume
400
Avg. Volume
6
Mkt Cap
333.93M
P/E Ratio
24.14
Dividend Yield
2.13%
Dividend
0.3

Upcoming

Dividends

2.13%Dividend Yield
May 26
$0.30
May 25
$0.26
May 24
$0.21
May 23
$0.22
May 22
$0.20
10Y Growth
4.99%
5Y Growth
27.33%
3Y Growth
11.29%
1Y Growth
15.81%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.91
1.2
1.48
1.76
Expected EPS
1.4446365160654797
Actual EPS
N/A

Financials

20.14%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
80.56MRevenue
16.23MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLVSF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers digital imaging systems in clinical diagnostics, competing in the digital cell morphology space with Cellavision.
Danaher
DHR
Mkt Cap151.89B
Danaher, through its subsidiaries like Beckman Coulter, provides hematology analyzers and related laboratory equipment, directly competing with Cellavision's digital microscopy and image analysis technologies.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation offers microscopy and diagnostic solutions that overlap with Cellavision's digital cell imaging and analysis market.
Agilon Health
AGL
Mkt Cap1.55B
Agilent Technologies offers a range of analytical instruments, including cell analysis solutions that compete with Cellavision's digital microscopy in the life sciences and diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of analytical and diagnostic equipment, including cell imaging systems that compete with Cellavision's offerings.
Resmed
RMD
Mkt Cap34.67B
ResMed, while primarily focused on sleep and respiratory markets, has ventured into health informatics and diagnostic software that could indirectly compete with Cellavision's digital analysis tools.
Illumina
ILMN
Mkt Cap32.55B
Illumina, known for its genetic variation and function systems, also offers imaging and analysis solutions that could compete with Cellavision in genomics and pathology markets.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health, primarily focused on liquid biopsy, also develops digital and analytical tools for cancer diagnostics, potentially competing with Cellavision's imaging and analysis technologies.

About

CellaVision AB (publ), a company established in Lund, Sweden, in 1994, specializes in the development and distribution of digital analytical solutions for blood and body fluid samples. Their offerings cater to the healthcare services sector, with a significant global presence spanning Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific region. The company's product portfolio includes advanced hardware such as the CellaVision DM1200 and CellaVision DM9600, which are designed to automatically capture digital images from blood smears and various body fluid preparations, alongside the CellaVision DC-1 analyzer. Complementing their instrumentation is a suite of specialized software applications. For instance, the CellaVision Peripheral Blood Application streamlines and standardizes the morphological examination of peripheral blood smears for laboratory professionals. Similarly, the CellaVision Advanced RBC Application facilitates a comprehensive evaluation of red blood cell morphology, while the CellaVision Body Fluid Application offers automated and standardized analysis for body fluid preparations. To enhance collaboration and flexibility, the CellaVision Remote Review Software eliminates geographical barriers in the smear review process. Further enriching their ecosystem are tools such as the CellaVision Server Software, which unifies workflows across single or multiple testing sites, and the CellaVision Dashboard, providing instant insights into analyzer and reviewer performance metrics. For staff development, the cloud-based CellaVision Proficiency Software aids laboratory managers in assessing and enhancing team competency in cell morphology. Educational resources include CellaVision CellAtlas, combining mini-lectures with an extensive cell image database. Finally, CellaVision VET extends their digital microscopy solutions to the field of veterinary hematology. Their clientele primarily consists of hospital and commercial diagnostic laboratories.
Show more...
CEO
Steve Ferguson
Employees
241
Country
Sweden
ISIN
SE0000683484
WKN
000A0NEVD

Listings

0 Comments

Share your thoughts

FAQ

What is Cellavision AB stock price today?
The current price of CLVSF is $14.00 USD — it has increased by +3.78% in the past 24 hours. Watch Cellavision AB stock price performance more closely on the chart.
What is Cellavision AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Cellavision AB stocks are traded under the ticker CLVSF.
Is Cellavision AB stock price growing?
CLVSF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Cellavision AB has showed a -39.99% decrease.
What is Cellavision AB market cap?
Today Cellavision AB has the market capitalization of 333.93M
When is the next Cellavision AB earnings date?
Cellavision AB is going to release the next earnings report on October 29, 2026.
What were Cellavision AB earnings last quarter?
CLVSF earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.14 USD resulting in a +2.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cellavision AB revenue for the last year?
Cellavision AB revenue for the last year amounts to 80.56M USD.
What is Cellavision AB net income for the last year?
CLVSF net income for the last year is 16.23M USD.
Does Cellavision AB pay dividends?
Yes, CLVSF dividends are paid annual. The last dividend per share was 0.3 USD. As of today, Dividend Yield (FWD)% is 2.13%.
How many employees does Cellavision AB have?
As of September 05, 2026, the company has 241 employees.
In which sector is Cellavision AB located?
Cellavision AB operates in the Health & Wellness sector.
When did Cellavision AB complete a stock split?
Cellavision AB has not had any recent stock splits.
Where is Cellavision AB headquartered?
Cellavision AB is headquartered in Lund, Sweden.